Will These 4 Large-Cap Drug Stocks Be Big Winners This Earnings Season?

2017 was a good year for pharma and biotech stocks with the sector witnessing some positive developments that led to a much-awaited recovery.Investing in such stocks could prove beneficial for investors as an earnings beat usually leads to significant share price appreciation.